Changes in the brain transcriptome after DNA Aβ42 trimer immunization in a 3xTg-AD mouse model.

Area of Science:

• Neuroscience
• Immunology
• Genetics

Background:

• Alzheimer's disease (AD) is linked to amyloid beta (Aβ) accumulation.
• Immunotherapy targeting Aβ shows promise for AD prevention.

Purpose of the Study:

• To evaluate the efficacy of DNA Aβ42 trimer immunization in a mouse model of AD.
• To investigate the impact of this immunotherapy on pathology, survival, gene expression, and synaptic function.

Main Methods:

• Immunization of 3xTg-AD mice with a DNA Aβ42 trimer construct.
• Assessment of cognitive behaviors (nest building) and survival rates.
• Analysis of gene expression in brain tissue using transcriptomics.

Main Results:

• DNA Aβ42 immunized mice exhibited improved nest building and increased 24-month survival rates.
• Vaccination downregulated upregulated genes associated with neuroinflammation and apoptosis in AD brains.
• Levels of immediate early genes involved in synaptic plasticity were restored to wild-type levels in immunized mice.

Conclusions:

• DNA Aβ42 immunotherapy effectively reduces AD pathology and improves cognitive and survival outcomes in a mouse model.
• The immunotherapy modulates neuroinflammatory pathways and enhances synaptic function, indicating potential for disease prevention.
• This approach extends beyond the amyloid hypothesis, offering a broader strategy for Alzheimer's disease intervention.